首页> Blood> Sustained minimal residual disease negativity in newly diagnosed multiple myeloma and the impact of daratumumab in MAIA and ALCYONE.

Sustained minimal residual disease negativity in newly diagnosed multiple myeloma and the impact of daratumumab in MAIA and ALCYONE.

导出 OA

翻译打印收藏纠错

第一作者： Jesus,San-Miguel

第一单位： Clínica Universidad de Navarra, Centro de Investigación Médica Aplicada (CIMA), Instituto de Investigación Sanitaria de Navarra (IDISNA), CIBER-ONC number CB16/12/00369, Pamplona, Spain.

作者： Jesus,San-Miguel ^[1] ; Hervé,Avet-Loiseau ^[2] ; Bruno,Paiva ^[1] ; Shaji,Kumar ^[3] ; Meletios A,Dimopoulos ^[4] ; Thierry,Facon ^[5] ; María-Victoria,Mateos ^[6] ; Cyrille,Touzeau ^[7] ; Andrzej,Jakubowiak ^[8] ; Saad Z,Usmani ^[9] ; Gordon,Cook ^[10] ; Michele,Cavo ^[11] ; Hang,Quach ^[12] ; Jon,Ukropec ^[13] ; Priya,Ramaswami ^[14] ; Huiling,Pei ^[14] ; Mia,Qi ^[15] ; Steven,Sun ^[15] ; Jianping,Wang ^[15] ; Maria,Krevvata ^[16] ; Nikki,DeAngelis ^[16] ; Christoph,Heuck ^[16] ; Rian,Van Rampelbergh ^[17] ; Anupa,Kudva ^[15] ; Rachel,Kobos ^[15] ; Ming,Qi ^[16] ; Nizar J,Bahlis ^[18]

作者单位： Clínica Universidad de Navarra, Centro de Investigación Médica Aplicada (CIMA), Instituto de Investigación Sanitaria de Navarra (IDISNA), CIBER-ONC number CB16/12/00369, Pamplona, Spain. ^[1] Unite de Genomique du Myelome, IUC-Oncopole, Toulouse, France. ^[2] Department of Hematology, Mayo Clinic, Rochester, MN. ^[3] National and Kapodistrian University of Athens, Athens, Greece. ^[4] University of Lille, CHU Lille, Service des Maladies du Sang, Lille, France. ^[5] University Hospital of Salamanca/IBSAL/Cancer Research Center-IBMCC (USAL-CSIC), Salamanca, Spain. ^[6] Hematology, University Hospital Hôtel-Dieu, Nantes, France. ^[7] University of Chicago Medical Center, Chicago, IL. ^[8] Levine Cancer Institute/Atrium Health, Charlotte, NC. ^[9] Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust and University of Leeds, Leeds, United Kingdom. ^[10] IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli," Università di Bologna, Bologna, Italy. ^[11] University of Melbourne, St. Vincent's Hospital, Melbourne, VIC. ^[12] Janssen Global Medical Affairs, Horsham, PA. ^[13] Janssen Research & Development, LLC, Titusville, NJ. ^[14] Janssen Research & Development, LLC, Raritan, NJ. ^[15] Janssen Research & Development, LLC, Spring House, PA. ^[16] Janssen Research & Development, Beerse, Belgium; and. ^[17] Arnie Charbonneau Cancer Research Institute, University of Calgary, Calgary, AB, Canada. ^[18]